Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지
DOI QR코드

DOI QR Code

Sports Pharmacy: New Specialty of Pharmacists and Pharmaceutical Care Services

스포츠 약학: 새로운 영역의 약사 역할과 전문 약료서비스 준비

  • Kim, Sung Hwa (Graduate School of Pharmaceutical Sciences, Ewha Womans University) ;
  • Cho, Sora (College of Pharmacy, Ewha Womans University) ;
  • Choi, Jae Hee (Division of Life and Pharmaceutical Sciences, Ewha Womans University) ;
  • Lee, Young-Hee (Department of Rehabilitation Medicine, Yonsei University Wonju College of Medicine) ;
  • Rhie, Sandy Jeong (Graduate School of Pharmaceutical Sciences, Ewha Womans University)
  • 김승화 (이화여자대학교 약학과 대학원) ;
  • 조소라 (이화여자대학교 약학대학) ;
  • 최재희 (이화여자대학교 대학원 생명약학부) ;
  • 이영희 (연세대학교 원주의과대학 재활의학교실) ;
  • 이정연 (이화여자대학교 약학과 대학원)
  • Received : 2021.02.18
  • Accepted : 2021.03.18
  • Published : 2021.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

The World Anti-Doping Agency has made efforts to promote the safe use of medications and prevent doping in sports globally. International standards have been established and experts have advocate anti-doping education to athletes and healthcare professionals. Pharmacists are expected to participate in the pharmaceutical care activity of sports medicine in protecting the athletes while providing the spirits of clean sports. In this review, we described the pharmacists' roles and functions in six areas of sports pharmaceutical care: awareness, treatment, prevention, optimization, abuse, and monitoring. Sports pharmacists should be able to prevent inappropriate drug use and manage athletes' illness and injury using pharmacotherapy. Further pharmacists should actively involve to educate and counsel athletes, trainers, and healthcare teams. In conclusion, pharmacists are expected to play important roles in sports pharmacy, which is the emerging area of specialized pharmaceutical care services.

Keywords

References

  1. WADA. International standard for education (ISE) 2021. Available from https://www.wada-ama.org/en/resources/the-code/internationalstandard-for-education-ise. Accessed February 6, 2021.
  2. Mottram D, Stuart M. The emerging specialty of sports pharmacy ASPETAR-Sports Medicine Journal 2013;1:66-71.
  3. Auersperger I, Topic MD, Maver P, Pusnik VK, Osredkar J, Lainscak M. Doping awareness, views, and experience: a comparison between general practitioners and pharmacists. Wien Klin Wochenschr 2012;124(1-2):32-8. https://doi.org/10.1007/s00508-011-0077-x
  4. WADA. Prohibited list 2021. Available from https://www.wadaama.org/en/what-we-do/the-prohibited-list. Accessed February 6, 2021.
  5. Malve HO. Sports pharmacology: a medical pharmacologist's perspective. J Pharm Bioallied Sci 2018;10(3):126-36. https://doi.org/10.4103/jpbs.jpbs_229_17
  6. Backhouse SH, McKenna J. Doping in sport: a review of medical practitioners' knowledge, attitudes and beliefs. Inter J Drug Policy 2011;22(3):198-202. https://doi.org/10.1016/j.drugpo.2011.03.002
  7. Goldberg L, Elliot D, Clarke GN, et al. Effects of a multidimensional anabolic steroid prevention intervention: The Adolescents Training and Learning to Avoid Steroids (ATLAS) program. JAMA 1996;276(19):1555-62. https://doi.org/10.1001/jama.1996.03540190027025
  8. Sagoe D, Holden G, Rise ENK. Doping prevention through anti-doping education and practical strength training: The Hercules program. Performance Enhancement and Health 2016;5(1):24-30. https://doi.org/10.1016/j.peh.2016.01.001
  9. Mottram D, Khalifa S, Alemrayat B, et al. Perspective of pharmacists in Qatar regarding doping and anti-doping in sports. J Sports Med Phys Fitness 2016;56(6):817-24.
  10. Yee KC, De Marco M, Salahudeen MS, et al. Pharmacists as a source of advice on medication use for athletes. Pharmacy 2020;8(1):10. https://doi.org/10.3390/pharmacy8010010
  11. Hainline B, Derman W, Vernec A, et al. International Olympic Committee consensus statement on pain management in elite athletes. Br J Sports Med 2014;51(17):1245-58. https://doi.org/10.1136/bjsports-2017-097884
  12. Ferry B, DeCastro A, Bragg S. Common prescription medications used in athletes. Prim Care 2020;47(1):49-64. https://doi.org/10.1016/j.pop.2019.10.003
  13. Matava MJ. Injectable nonsteroidal anti-inflammatory drugs in sport. Clin J Sport Med 2018;28(5):443-50. https://doi.org/10.1097/JSM.0000000000000602
  14. Alaranta A, Alaranta H, Helenius I. Use of prescription drugs in athletes. Sports Med 2008;38(6):449-63. https://doi.org/10.2165/00007256-200838060-00002
  15. Golzari H, Dawson NV, Speroff T, Thomas C. Prolonged QTc intervals on admission electrocardiograms: prevalence and correspondence with admission electrolyte abnormalities. Conn Med 2007;71(7):389-97.
  16. Gleeson M, Pyne DB. Respiratory inflammation and infections in high-performance athletes. Immuno Cell Biol 2016;94(2):124-31. https://doi.org/10.1038/icb.2015.100
  17. Asplund C. Treatment of hypertension in athletes: an evidence-based review. Phys Sportsmed 2010;38(1):37-44. https://doi.org/10.3810/psm.2010.04.1760
  18. Pelto H. Hypertensive medications in competitive athletes. Curr Sports Med Rep 2017;16(1):45-9. https://doi.org/10.1249/JSR.0000000000000325
  19. KADA. Therapeutic use exemption. Available from https://kadaad.or.kr/kada?where=tue/tue_intro. Accessed February 6, 2021.
  20. Kaufman KR. Anticonvulsants in sports: ethical considerations. Epilepsy Behav 2007;10(2):268-71. https://doi.org/10.1016/j.yebeh.2006.12.004
  21. Wheeler P, Batt M. Do non-steroidal anti-inflammatory drugs adversely affect stress fracture healing? a short review. Br J Sports Med 2005;39(2):65-9. https://doi.org/10.1136/bjsm.2004.012492
  22. Maughan RJ, Burke LM, Dvorak J, et al. IOC consensus statement: dietary supplements and the high-performance athlete. Int J Sport Nutr Exerc Metab 2018;28(2):104-25. https://doi.org/10.1123/ijsnem.2018-0020
  23. Howard MS, DiDonato KL, Janovick DL, et al. Perspectives of athletes and pharmacists on pharmacist-provided sports supplement counseling: an exploratory study. J Am Pharm Assoc 2018;58(4S): S30-S36.e2. https://doi.org/10.1016/j.japh.2018.05.003
  24. Edenfield KM. Sports Supplements: Pearls and Pitfalls. Prim Care 2020;47(1):37-48. https://doi.org/10.1016/j.pop.2019.10.002
  25. Hao Q, Dong BR, Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev 2015;(2):CD006895.
  26. Bhatt DL, Steg PG, Miller M, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med 2019;380(1):11-22. https://doi.org/10.1056/NEJMoa1812792
  27. Barrett EC, McBurney MI, Ciappio ED. ω-3 fatty acid supplementation as a potential therapeutic aid for the recovery from mild traumatic brain injury/concussion. Adv Nutr 2014;5(3):268-77. https://doi.org/10.3945/an.113.005280
  28. Endo J, Arita M. Cardioprotective mechanism of omega-3 polyunsaturated fatty acids. J Cardio 2016;67(1):22-7. https://doi.org/10.1016/j.jjcc.2015.08.002
  29. Lewis NA, Daniels D, Calder PC, Castell LM, Pedlar CR. Are there benefits from the use of fish oil supplements in athletes? A systematic review. Adv Nutr 2020;11(5):1300-14. https://doi.org/10.1093/advances/nmaa050
  30. Ganio MS, Klau JF, Casa DJ, Armstrong LE, Maresh CM. Effect of caffeine on sport-specific endurance performance: a systematic review. J Strength Cond Res 2009;23(1):315-24. https://doi.org/10.1519/jsc.0b013e31818b979a
  31. Peeling P, Binnie MJ, Goods PS, Sim M, Burke LM. Evidence-based supplements for the enhancement of athletic performance. Int J Sport Nutr Exerc Metab 2018;28(2):178-87. https://doi.org/10.1123/ijsnem.2017-0343
  32. Martinez-Sanz JM, Sospedra I, Ortiz CM, Baladia E, Gil-Izquierdo A, Ortiz-Moncada R. Intended or unintended doping? A review of the presence of doping substances in dietary supplements used in sports. Nutrients 2017;9(10):1093. https://doi.org/10.3390/nu9101093
  33. Kondric M, Sekulic D, Petroczi A, Ostojic L, Rodek J, Ostojic Z. Is there a danger for myopia in anti-doping education? Comparative analysis of substance use and misuse in Olympic racket sports calls for a broader approach. Subst Abuse Treat Prev Policy 2011;6:27. https://doi.org/10.1186/1747-597X-6-27
  34. Gaffney GR, Parisotto R. Gene doping: a review of performance-enhancing genetics. Pediatr Clin North Am 2007;54(4):807-22. https://doi.org/10.1016/j.pcl.2007.04.004
  35. van der Gronde T, de Hon O, Haisma HJ, Pieters T. Gene doping: an overview and current implications for athletes. Br J Sports Med 2013;47(11):670-8. https://doi.org/10.1136/bjsports-2012-091288
  36. Hatton CK, Green GA, Ambrose PJ. Performance-enhancing drugs: understanding the risks. Phys Med Rehabil Clin N Am 2014;25(4): 897-913. https://doi.org/10.1016/j.pmr.2014.06.013
  37. Tandon S, Bowers LD, Fedoruk MN. Treating the elite athlete: anti-doping information for the health professional. Mo Med 2015; 112(2):122-8.
  38. Gamelin F-X, Cuvelier G, Mendes A, et al. Cannabidiol in sport: Ergogenic or else? Pharmacol Res 2020;156:104764. https://doi.org/10.1016/j.phrs.2020.104764
  39. Scharf M, Zurawski N, Ruthenberg T. Negotiating privacy. Athletes' assessment and knowledge of the ADAMS. Perform Enhanc Health 2018;6(2):59-68. https://doi.org/10.1016/j.peh.2018.07.002
  40. Wang G, Karanikolou A, Verdouka I, Friedmann T, Pitsiladis Y. Next generation "omics" approaches in the "fight" against blood doping. Med Sport Sci 2017;62:119-28. https://doi.org/10.1159/000470919
  41. Hyun J. Geneticizing ethnicity and diet: Anti-doping science and Its social impact in the age of post-genomics. Front Genet 2017;8:56. https://doi.org/10.3389/fgene.2017.00056
  42. Webborn N, Williams A, McNamee M, et al. Direct-to-consumer genetic testing for predicting sports performance and talent identification: consensus statement. Br J Sports Med 2015;49(23):1486-91. https://doi.org/10.1136/bjsports-2015-095343
  43. Hooper AD, Cooper JM, Schneider J, Kairuz T. Current and potential roles in sports pharmacy: A systematic review. Pharmacy (Basel) 2019;7(1):29. https://doi.org/10.3390/pharmacy7010029
  44. Stuart M, Kwon YI, Rhie SJ. Pharmacy services at the PyeongChang 2018 Olympic and Paralympic winter games. Br J Sports Med 2019;53(17):1105-10. https://doi.org/10.1136/bjsports-2018-100069
  45. Bomfim JHGG. Pharmaceutical Care in Sports. Pharmacy (Basel) 2020;8(4):218. https://doi.org/10.3390/pharmacy8040218
  46. Ambrose PJ. An advanced pharmacy practice experience in sports pharmacy. Am J Pharm Educ 2008;72(1):19. https://doi.org/10.5688/aj720119
  47. Sipaviciute B, Sukys S, Dumciene A. Doping prevention in sport: Overview of anti-doping education programmes. Balt J Sport Health Sci 2020;2(117).
  48. Gatterer K, Gumpenberger M, Overbye M, Streicher B, Schobersberger W, Blank C. An evaluation of prevention initiatives by 53 national anti-doping organizations: achievements and limitations. J Sport Health Sci 2020;9(3):228-39. https://doi.org/10.1016/j.jshs.2019.12.002
  49. Ambrose PJ. Educational opportunities and anti-doping roles and responsibilities for pharmacists. Yakugaku Zasshi 2011;131(12):1761-4. https://doi.org/10.1248/yakushi.131.1761